ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, ViiV is determined to help end the HIV epidemic. The company is guided by its mission to leave no person living with HIV behind and combines expertise in research, manufacturing, policy, and more to push the boundaries of what is possible in HIV treatment and care. As a result of its connection with GSK, it draws on GSK's history and resources while maintaining a dedicated focus on HIV.
